A new study suggests steroids could blunt the effects of some immunotherapies, but researchers say they remain necessary for some patients.

by Kyle Bagenstose

Potential new approach to treating diffuse intrinsic pontine glioma uses engineered immune cells infused directly to the brain.

by Taneia Surles

Researchers find no evidence that immune checkpoint inhibitors benefit cancer patients getting inpatient care. They urge earlier consideration of palliative care.

by Kyle Bagenstose

Scientists present data on the risks of immune checkpoint inhibitors so more patients can tap into the treatment.

by Marci A. Landsmann

Combining an immune checkpoint inhibitor with standard care extended event-free survival by nearly two years.

by Thomas Celona

Forward Look

Immunotherapy can induce a complete response in some people with mismatch repair-deficient cancers.

by Thomas Celona

Giving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.

by Laura Gesualdi-Gilmore

The drug showed promise in treating small cell lung cancer that had progressed during or after chemotherapy.

by Laura Gesualdi-Gilmore

Scientists thought pancreatic cancer wouldn’t respond to immunotherapy. Now research has found vaccines can trigger the immune system to fight the disease.

by Thomas Celona

The recently approved immunotherapy Amtagvi uses a patient’s own immune cells to destroy advanced melanoma.

by Sandra Gordon